Evidence map›Paper›PMID 23684991›Full record

ArticleNeuropharmacology2014

A mechanistic hypothesis of the factors that enhance vulnerability to nicotine use in females.

Laura E O'Dell, Oscar V Torres

Abstract read
In one paragraph

Article in Neuropharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 2 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 2 syntheses or guidelines pooled it, 76 citations in OpenAlex.

  1. Pooled it
  2. Systematic and meta-analytic review of research examining the impact of menstrual cycle phase and ovarian hormones on smoking and cessation.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2015
    Pooled it
  3. Article
  4. Article
  5. Article
  6. Factors influencing JUUL e-cigarette nicotine vapour-induced reward, withdrawal, pharmacokinetics and brain connectivity in rats: sex matters.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Nicotine and the developing brain: Insights from preclinical models.Pharmacology, biochemistry, and behavior · 2022
    Article
  12. Article
  13. Self-Administration of Cotinine in Wistar Rats: Comparisons to Nicotine.The Journal of pharmacology and experimental therapeutics · 2021
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Evaluation of Sex Differences in the Elasticity of Demand for Nicotine and Food in Rats.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Laura E O'DellDepartment of Psychology, The University of Texas at El Paso, El Paso, TX 79902, USA. Electronic address: lodell@utep.edu.
Oscar V Torres
The University of Texas at El Paso · US

Funding

TCCG12MD007592 · NIMHD · UNIVERSITY OF TEXAS EL PASO · PI KIRKEN, ROBERT A. · 2012 to 2018
$19.4M
Sex Differences in the Mechanisms that Promote Nicotine Reward and WithdrawalR01DA021274 · NIDA · UNIVERSITY OF TEXAS EL PASO · PI ODELL, LAURA ELENA · 2007 to 2019
$4.4M
UTEP DIDARP: Vulnerability Issues in Drug Abuse (VIDA)R24DA029989 · NIDA · UNIVERSITY OF TEXAS EL PASO · PI CASTANEDA, EDWARD · 2011 to 2015
$2.1M
Summer Mentoring And Research Training: Methods In Neuroscience of Drug-abuse (SMART-MIND)R25DA033613 · NIDA · UNIVERSITY OF TEXAS EL PASO · PI Karina C Canaba, LAURA ELENA ODELL · 2012 to 2026
$1.5M
NIDA NIH HHS R01 DA021274NIDA NIH HHS R01-DA021274NIDA NIH HHS R24 DA029989NIDA NIH HHS R24-DA029989NIDA NIH HHS R25 DA033613NIDA NIH HHS R25-DA033613NIMHD NIH HHS G12 MD007592NIMHD NIH HHS G12MD007592
6 · The paper itself

Abstract

Women are particularly more vulnerable to tobacco use than men. This review proposes a unifying hypothesis that females experience greater rewarding effects of nicotine and more intense stress produced by withdrawal than males. We also provide a neural framework whereby estrogen promotes greater rewarding effects of nicotine in females via enhanced dopamine release in the nucleus accumbens (NAcc). During withdrawal, we suggest that corticotropin-releasing factor (CRF) stress systems are sensitized and promote a greater suppression of dopamine release in the NAcc of females versus males. Taken together, females display enhanced nicotine reward via estrogen and amplified effects of withdrawal via stress systems. Although this framework focuses on sex differences in adult rats, it is also applied to adolescent females who display enhanced rewarding effects of nicotine, but reduced effects of withdrawal from this drug. Since females experience strong rewarding effects of nicotine, a clinical implication of our hypothesis is that specific strategies to prevent smoking initiation among females are critical. Also, anxiolytic medications may be more effective in females that experience intense stress during withdrawal. Furthermore, medications that target withdrawal should not be applied in a unilateral manner across age and sex, given that nicotine withdrawal is lower during adolescence. This review highlights key factors that promote nicotine use in females, and future studies on sex-dependent interactions of stress and reward systems are needed to test our mechanistic hypotheses. Future studies in this area will have important translational value toward reducing health disparities produced by nicotine use in females. This article is part of a Special Issue entitled 'NIDA 40th Anniversary Issue'.

Indexed as

RewardSex CharacteristicsAdolescentAdolescent BehaviorAnimalsFemaleHumansMaleTobacco Use DisorderAdolescentDependenceRewardSexTobaccoWithdrawal

Identifiers

PMID23684991
PMCPMC3812395
OpenAlexW1986230975

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.